Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JAMA Cardiology
Payers
New study finds 137M US adults are eligible for GLP-1s
Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American adults would benefit from the drugs.
Paige Minemyer
Nov 25, 2024 4:00pm
Study: Lower heart disease mortality rates in expansion states
Jun 7, 2019 8:42am
Odds of surviving cardiac arrest vary based on EMS agency: study
Sep 26, 2018 12:56pm
Malpractice caps influence doctors’ decisions—roundup
Jun 7, 2018 12:49pm
Readmissions program linked to higher death rates
Nov 13, 2017 11:55am
Study: Readmission penalties do not lead to improved outcomes
Apr 28, 2017 12:18pm
